Skip to content

Clinical trials

Lymphoma, T-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Country / region: United States Clear all

172 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20043
20051
20064
20074
20087
20099
20105
20119
20125
201311
20145
20155
20168
201715
20188
201915
202010
20217
20224
20238
20248
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Recruiting36
Terminated31
Active, not recruiting14
Withdrawn4
Suspended2
Unknown status2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)20
M.D. Anderson Cancer Center15
City of Hope Medical Center8
Memorial Sloan Kettering Cancer Center8
Mayo Clinic7
Fred Hutchinson Cancer Center6
Masonic Cancer Center, University of Minnesota5
Yale University5
Acrotech Biopharma Inc.3
Dana-Farber Cancer Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell172
Lymphoma52
Lymphoma, Non-Hodgkin42
Lymphoma, Large-Cell, Anaplastic37
Lymphoma, T-Cell, Cutaneous37
Leukemia, Lymphocytic, Chronic, B-Cell32
Lymphoma, B-Cell31
Lymphoma, Follicular31
Lymphoma, Mantle-Cell31
Hodgkin Disease30

Trials

Showing 26 to 50 of 172. Each trial links to its page on Pharma Observatory.

72 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.